The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Amniocentesis

Amniocentesis — an advanced diagnostic test performed by sampling amniotic fluid during pregnancy.

A procedure usually performed at 16-20 weeks of pregnancy in which an amniotic fluid sample is obtained under ultrasound guidance for chromosomal and genetic evaluation of the fetus.

Indication

  • High risk identified on screening tests (dual, triple, quadruple test, NIPT)
  • Increased risk of chromosomal abnormality due to maternal age or family history
  • Suspicious structural anomaly seen on ultrasound
  • History of chromosomal or genetic disease in a previous pregnancy
  • Prenatal diagnosis in known carriers of genetic disease
  • Evaluation of fetal lung maturity at advanced gestational ages (selected cases)
  • Evaluation of suspected intrauterine infection

Preparation

  • Detailed information is provided and informed consent is obtained before the procedure
  • Fasting is not required; a light meal can be eaten
  • Rh immunoglobulin (anti-D) preparation is planned for Rh-negative mothers
  • Use of blood-thinning medications must be reported to the physician in advance
  • Whether the bladder should be full or empty is determined by the physician according to the procedure

How it's performed

  1. The patient is positioned supine and the abdominal area is sterilized
  2. Using ultrasound, the appropriate pocket of the baby, placenta, and amniotic fluid is identified
  3. A thin, long needle is inserted through the abdominal skin into the amniotic sac under ultrasound guidance
  4. Approximately 15-20 ml of amniotic fluid sample is collected
  5. After the needle is withdrawn, the entry site is closed and the baby's heartbeat is checked
  6. The procedure typically takes 5-10 minutes; the sample is sent to a genetic laboratory

Post-procedure

  • After the procedure, avoidance of heavy lifting, long travel, and intense activity is recommended for 24-48 hours
  • Mild abdominal cramping or pressure sensation is normal; if fever, bleeding, fluid leakage, or severe pain occurs, consult a physician
  • Anti-D immunoglobulin is given to Rh-negative mothers
  • Results are usually available within 2-5 days for rapid tests and 2-3 weeks for full karyotype
  • Genetic counseling and further evaluation are planned based on the results

Risks

  • Risk of miscarriage is approximately 0.1-0.3% (in experienced hands)
  • Mild vaginal bleeding or amniotic fluid leakage may occur
  • Rarely, intrauterine infection may develop
  • Very rarely, contact with the baby or placenta with the needle
  • Risk of sensitization in Rh-incompatible mothers if anti-D is not administered

FAQ

When is amniocentesis performed?

Amniocentesis for genetic purposes is generally performed between 16-20 weeks of pregnancy. Performing it at earlier weeks may increase the risk of miscarriage.

Is amniocentesis painful?

During the procedure, a brief stinging at needle entry and a mild pressure sensation are usually felt. Severe pain is not expected.

What is the risk of miscarriage?

In experienced centers, the procedure-related risk of miscarriage is reported at approximately 0.1-0.3%. The decision is made by weighing this risk against individual risk-benefit balance.

What is the difference from NIPT?

NIPT (a screening test from maternal blood) is a screening tool and is non-invasive; amniocentesis is a diagnostic test that gives a definitive result. Amniocentesis may be recommended to confirm positive or high-risk NIPT findings.

Related Information